Adisan Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 29-07-2024
- Paid Up Capital ₹ 2.50 M
as on 29-07-2024
- Company Age 14 Year,
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 15.17 Cr
as on 29-07-2024
- Satisfied Charges ₹ 9.39 Cr
as on 29-07-2024
- Revenue -11.89%
(FY 2023)
- Profit -53.41%
(FY 2023)
- Ebitda -3.40%
(FY 2023)
- Net Worth 11.89%
(FY 2023)
- Total Assets 0.71%
(FY 2023)
About Adisan Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹15.17 Cr. The company has closed loans amounting to ₹9.39 Cr, as per Ministry of Corporate Affairs (MCA) records.
Aditya Devadhar and Suvarnarekha Devadhar serve as directors at the Company.
- CIN/LLPIN
U74900PN2010PTC138049
- Company No.
138049
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Dec 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Mulshi, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Adisan Laboratories Private Limited offer?
Adisan Laboratories Private Limited offers a wide range of products and services, including Acaricide, Cypermethrin, Industrial Chemicals & Supplies, Disinfectant Chemicals, Biocides, Animal Medicines & Health Care, Veterinary Medicines, Soaps, Detergent Powder & Cakes, Detergent Powder, Insecticides and Pesticides.
Who are the key members and board of directors at Adisan Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aditya Devadhar  | Director | 22-Dec-2010 | Current |
| Suvarnarekha Devadhar | Director | 22-Dec-2010 | Current |
Financial Performance of Adisan Laboratories.
Adisan Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 11.89% decrease. The company also saw a substantial fall in profitability, with a 53.41% decrease in profit. The company's net worth Soared by an impressive increase of 11.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adisan Laboratories?
In 2023, Adisan Laboratories had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Adisan Biotechnologies Private LimitedActive 12 years 4 monthsAditya Devadhar and Suvarnarekha Devadhar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 Aug 2018 | ₹15.17 Cr | Open |
Others Creation Date: 28 Feb 2022 | ₹1.09 Cr | Satisfied |
Others Creation Date: 27 Feb 2017 | ₹2.31 Cr | Satisfied |
How Many Employees Work at Adisan Laboratories?
Adisan Laboratories has a workforce of 42 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adisan Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adisan Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
